The European Parliament supports negotiations leading to “a temporary waiver” from the Trade-Related Aspects of Intellectual Property Rights (TRIPS) agreement “to enhance global access to affordable Covid-19-related medical products and to address global production constraints and supply shortages”, in a non-binding resolution it adopted on Thursday 10 June (355 votes in favour, 263 against, 71 abstentions).
This specific amendment by the Greens/EFA Group was adopted by one vote...